Fetal loss following invasive prenatal testing: a comparison of transabdominal chorionic villus sampling, transcervical chorionic villus sampling and amniocentesis

Abstract Objective: The aim of this study was to compare transabdominal chorionic villus sampling, transcervical chorionic villus sampling and amniocentesis with respect to their total fetal loss rates. Methods: We retrospectively evaluated procedures of invasive prenatal testing performed during a 14-year period (2001–2014) including 936 amniocentesis procedures and 1051 chorionic villus samplings, of which 405 cases were executed transabdominally and 646 transcervically. Only singleton pregnancies before 24 weeks and 0 days of gestation where the pregnancy outcome was known were included. Fetal loss was defined as an abortion occurring either before 24 weeks and 0 days of gestation or <2 weeks after the procedure. Results: The total fetal loss rates were determined to be 1.73% for transabdominal chorionic villus sampling, 2.01% for transcervical chorionic villus sampling and 1.18% for amniocentesis. No statistically noticeable differences between the total fetal loss rates of all three procedures were found (P=0.399). Conclusion: Our study has shown that chorionic villus sampling (either transabdominal or transcervical) and amniocentesis are equal methods for invasive prenatal testing with respect to their abortion risk.

[1]  Zarko Alfirevic,et al.  Amniocentesis and chorionic villus sampling for prenatal diagnosis. , 2017, The Cochrane database of systematic reviews.

[2]  P. Antsaklis,et al.  Risk for fetal loss and prematurity after 12,413 second trimester amniocenteses in a single center , 2015, Journal of perinatal medicine.

[3]  F. D’Antonio,et al.  Procedure‐related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta‐analysis , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[4]  B. Levy,et al.  Noninvasive prenatal testing: the future is now. , 2013, Reviews in obstetrics & gynecology.

[5]  G. Macones,et al.  Effect of Maternal Obesity on the Risk of Fetal Loss After Amniocentesis and Chorionic Villus Sampling , 2012, Obstetrics and gynecology.

[6]  L. Impey,et al.  Prenatal diagnosis: types and techniques. , 2012, Early human development.

[7]  Z. Alfirevic,et al.  Update on Procedure-Related Risks for Prenatal Diagnosis Techniques , 2009, Fetal Diagnosis and Therapy.

[8]  A. Tabor,et al.  Fetal loss rate after chorionic villus sampling and amniocentesis: an 11‐year national registry study , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[9]  A. Tabor,et al.  Impact of a new national screening policy for Down’s syndrome in Denmark: population based cohort study , 2008, BMJ : British Medical Journal.

[10]  I. Staboulidou,et al.  Screening for Adverse Pregnancy Outcome by Ductus Venosus Doppler at 11–13+6 Weeks of Gestation , 2008, Obstetrics and gynecology.

[11]  A. Knippel,et al.  Individual Risk of Fetal Loss Following Routine Second Trimester Amniocentesis: A Controlled Study of 20 460 Cases , 2007, Ultraschall in der Medizin.

[12]  Z. Alfirevic,et al.  Procedure-Related Complications of Amniocentesis and Chorionic Villous Sampling: A Systematic Review , 2007, Obstetrics and gynecology.

[13]  E. Pajkrt,et al.  Increased nuchal translucency thickness and normal karyotype: time for parental reassurance , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[14]  K. Nicolaides,et al.  First‐trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death , 2006, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[15]  N. Papantoniou,et al.  Risk factors predisposing to fetal loss following a second trimester amniocentesis , 2001, BJOG : an international journal of obstetrics and gynaecology.

[16]  K. Nicolaides,et al.  Maternal age‐ and gestation‐specific risk for trisomy 21 , 1999, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[17]  D. James.  Fetal medicine , 1998, BMJ.

[18]  C. Lundsteen,et al.  Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling , 1992, The Lancet.

[19]  D. Ledbetter,et al.  A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group. , 1992, The New England journal of medicine.